While SIRT3, SIRT4, and SIRT6 are poised to induce tumor-suppressive autophagy, others, such as SIRT2 and SIRT7, are likely to stimulate protective autophagic programs that underlie tumor survival and drug resistance. Here, SIRT4 is linked to neoplasm.